Morgan Stanley upgrades Orsted stock rating on lower US project risk

Morgan Stanley upgraded Orsted to Overweight from Equalweight and lifted its price target to DKK225 from DKK160, implying 38% upside. The firm cites a 13% EPS CAGR from 2025 to 2030, lower US project risk, and potential re-rating catalysts from de-risking the Sunrise project and new project wins. Goldman Sachs also turned positive, raising its target to DKK185 from DKK150, reinforcing the constructive outlook for offshore wind and Europe’s electrification shift.

Analysis

The key read-through is not just that the sell-side is turning constructive on a single developer; it’s that capital is beginning to differentiate between de-risked offshore wind exposure and the rest of the sector. That matters because the group has been valued as if policy optionality and execution risk were still symmetric, when in practice balance-sheet strength and project de-risking create a much cleaner re-rating path than generic renewable exposure. The incremental winner is likely the utility/equipment ecosystem tied to late-stage offshore wind awards and grid buildout, while weaker balance-sheet peers remain vulnerable to being funded at punitive terms.

The second-order effect is on the capex cycle. If financing conditions improve for the strongest platforms, they can bid more aggressively for pipeline assets, which should tighten pricing for developers and potentially compress returns for marginal entrants over the next 6-18 months. In that sense, the upgrade is a signal that the market may be underestimating how quickly capital can move back into the space once one or two high-profile execution risks are resolved.

The main risk is timing: these are not immediate earnings catalysts, but medium-term rerating events that depend on project milestones and power-price realization. If rates stay elevated or if any US project de-risking slips, the market could quickly fade the narrative and re-anchor the name on balance-sheet optics rather than growth. The consensus may also be too linear on policy support; a more crowded renewable trade can mean better fundamentals but worse entry points if investors have already chased the move.

Key Decisions for Investors

• Buy ORSTED on pullbacks over the next 2-8 weeks; use the 2027 EV/EBITDA gap versus implied growth as the valuation anchor. Risk/reward is attractive if US project de-risking continues, but trim if the stock approaches the implied fair-value band before new project wins are visible.
• Pair trade: long ORSTED / short a higher-leverage European renewables developer or merchant-heavy utility over 3-6 months. The thesis is that the market will reward balance-sheet flexibility and punish names that still need external capital to fund growth.
• Consider a call spread in ORSTED with 3-6 month maturity to express upside from rerating while limiting downside if project catalysts slip. Structure should target the next catalyst window rather than a long-dated secular hold.
• Fade crowded clean-energy beta if rates back up: short a basket of lower-quality renewable equities against ORSTED if the sector rallies on policy headlines without project-specific de-risking. The relative trade should outperform on any dispersion event.
• Watch for a catalyst checklist rather than headline sentiment: Sunrise de-risking, new awards, and power-price upgrades. If none materialize within 1-2 quarters, reduce exposure because the market will likely revert to execution discounting.